Skip to main content
. Author manuscript; available in PMC: 2011 Apr 14.
Published in final edited form as: Immunol Rev. 2005 Aug;206:232–259. doi: 10.1111/j.0105-2896.2005.00280.x

Table 3. Experimental Disease Models Amelioratedby Oral Tolerance.

Disease Model Protein Fed
Airway Eosinophilia OVA
Allergy Derp1, cedar pollen
Anti-phospholipid Syndrome β2-glycoprotein
Arthritis (CIA, AA, AIA, PIA, SCW) Collagen II, Hsp65, BSA
Atherosclerosis Hsp65
Cardiac reperfusion injury Troponin
Colitis Colonic proteins, OVA
Diabetes (NOD mouse) Insulin, GAD, OVA
Encephalomyelitis (EAE) MBP, PLP, MOG, GA
Food Hypersensitivity aS1-casein
Myasthenia Gravis AchR
Neuritis PNS-myelin
Nickel Sensitization Nickel
Sogren's syndrome Rho peptides
Stroke MOG
Thyroiditis Thyroglobulin
Transplantation Alloantigen, MHC peptide
Uveitis S-Ag, IRBP
Nerve Injury MBP